Lipid peroxidation, arachidonic acid and products of the lipoxygenase pathway in ischaemic preconditioning of rat heart

Cardiovascular Research

Volumn 37, Issue 1, 1998, Pages 66-75

  Starkopf, Joel ^a   Andreasen, Thomas V ^b   Bugge, Einar ^b   Ytrehus, Kirsti ^b  

^a UNIVERSITY OF TARTU   (Estonia)

^b UNIVERSITY OF TROMSØ   (Norway)

Author keywords

Arachidonic acid; Ischemic preconditioning; Phospholipids; Rat heart

Indexed keywords

ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; LIPID PEROXIDE; LIPOXYGENASE; PHOSPHOLIPID;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; ISOLATED HEART; LIPID ANALYSIS; LIPID COMPOSITION; LIPID PEROXIDATION; MALE; NONHUMAN; PATHOPHYSIOLOGY; PHOSPHOLIPID METABOLISM; PRIORITY JOURNAL; RAT; SECOND MESSENGER;

ANALYSIS OF VARIANCE; ANIMALS; ARACHIDONIC ACID; DOCOSAHEXAENOIC ACIDS; FATTY ACIDS, NONESTERIFIED; FATTY ACIDS, UNSATURATED; ISCHEMIC PRECONDITIONING, MYOCARDIAL; LINOLEIC ACIDS; LIPID PEROXIDATION; LIPOXYGENASE; LIPOXYGENASE INHIBITORS; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; MYOCARDIUM; NORDIHYDROGUAIARETIC ACID; PERFUSION; PHOSPHOLIPIDS; RATS; RATS, WISTAR;

EID: 0031888412     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(97)00240-X     Document Type: Article

References (43)

1. Murry C.E., Jennings R.B., Reimer K.A. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 74:1986;1124-1136.
2. Sack S., Mohri M., Arras M., Schwarz E.R., Schaper W. Ischaemic preconditioning - time course of renewal in the pig. Cardiovasc Res. 27:1993;551-555.
3. Tanaka M., Fujiwara H., Yamasaki K., Sasayama S. Superoxide dismutase and N-2-mercaptopropionyl glycine attenuate infarct size limitation effect of ischaemic preconditioning in the rabbit. Cardiovasc Res. 28:1994;980-986.
4. Bolli R., Zughaib M., Li X.Y.et al. Recurrent ischemia in the canine heart causes recurrent bursts of free radical production that have a cumulative effect on contractile function. A pathophysiological basis for chronic myocardial 'stunning'. J Clin Invest. 96:1995;1066-1084.
5. Cave A.C., Collins C.S., Downey J.M., Hearse D.J. Improved functional recovery by ischaemic preconditioning is not mediated by adenosine in globally ischaemic heart. Cardiovasc Res. 27:1993;663-668.
6. Murphy E., Glasgow W., Fralix T., Steenbergen C. Role of lipoxygenase metabolites in ischemic preconditioning. Circ Res. 76:1995;457-467.
7. Armstrong S., Ganote C.E. Adenosine receptor specificity in preconditioning of isolated rabbit cardiomyocytes: evidence of A3 receptor involvement. Cardiovasc Res. 28:1994;1049-1056.
8. Goto M., Liu Y., Yang X.M., Ardell J.L., Cohen M.V., Downey J.M. Role of bradykinin in protection of ischemic preconditioning in rabbit hearts. Circ Res. 77:1995;611-621.
9. Zhou X., Zhai X., Ashraf M. Preconditioning of bovine endothelial cells. The protective effect is mediated by an adenosine A2 receptor through a protein kinase C signaling pathway. Circ Res. 78:1996;73-81.
10. Liu Y., Gao W.D., O'Rourke B., Marban E. Synergistic modulation of ATP-sensitive K+ currents by protein kinase C and adenosine. Implications for ischemic preconditioning. Circ Res. 78:1996;443-454.
11. Ytrehus K., Liu Y., Downey J.M. Preconditioning protects ischemic rabbit heart by protein kinase C activation. Am J Physiol. 266:1994;H1145-H1152.
12. Hu K., Nattel S. Mechanisms of ischemic preconditioning in rat hearts. Involvement of alpha-1-adrenoceptors, pertussis toxin-sensitive G proteins, and protein kinase C. Circulation. 92:1995;2259-2265.
13. Tsuchida A., Liu Y., Liu G.S., Cohen M.V., Downey J.M. Alpha 1-adrenergic agonists precondition rabbit ischemic myocardium independent of adenosine by direct activation of protein kinase C. Circ Res. 75:1994;576-585.
14. Li Y., Kloner R.A. Does protein kinase C play a role in ischemic preconditioning in rat hearts? Am J Physiol. 268:1995;H426-H431.
15. Speechly Dick M.E., Mocanu M.M., Yellon D.M. Protein kinase C. Its role in ischemic preconditioning in the rat. Circ Res. 75:1994;586-590.
16. Khan W.A., Blobe G.C., Hannun Y.A. Arachidonic acid and free fatty acids as second messengers and the role of protein kinase C. Cellular Signalling. 7:1995;171-184.
17. Damron D.S., Darvish A., Murphy L., Sweet W., Moravec C.S., Bond M. Arachidonic acid dependent phosphorylation of troponin I and myosin light chain-2 in cardiac myocytes. Circ Res. 76:1995;1011-1019.
18. Nishizuka Y. Protein kinase C and lipid signaling for sustained cellular responses. FASEB J. 9:1995;484-496.
19. Folch B.J., Lees M., Stanley H.S. A simple method for the isolation and purification of total lipids from animal tissues. Biol Chem. 226:1957;497-509.
20. Kalunzny M.A., Duncan L.A., Merritt M.V., Epps D.E. Rapid separation of lipid classes in high yield and purity using bonded phase columns. J Lipid Res. 26:1985;135-140.
21. Van Rollins M., Murphy R.C. Autooxidation of docosahexaenoic acid: analysis of ten isomers of hydroxydocosahexaenoate. J Lipid Res. 25:1984;507-51722.
22. Bugge K, Ytrehus E. Bradykinin protects against infarction but does not mediate ischemic preconditioning in the isolated rat heart. J Mol Cell Cardiol 1996;28:2333-2341.
23. Zhou X., Zhai X., Ashraf M. Direct evidence that initial oxidative stress triggered by preconditioning contributes to second window of protection by endogenous antioxidant enzyme in myocytes. Circulation. 93:1996;1177-1184.
24. Richard V., Tron C., Thuillez C. Ischaemic preconditioning is not mediated by oxygen derived free radicals in rats. Cardiovasc Res. 27:1993;2016-2021.
25. Fu L.X., Kirkeboen A., Liang Q.M., Sjögren K.G., Hjalmarson A. Free radical scavening enzymes and G protein mediated receptor signalling systems in ischaemically preconditioned porcine myocardium. Cardiovasc Res. 27:1993;612-616.
26. Turrens J.F., Thornton J., Barnard M.L., Downey J.M. Protection from reperfusion injury by preconditioning hearts does not involve increased antioxidant defences. Am J Physiol. 262:1992;H585-H589.
27. Potts B.C.M., Faulkner D.J. Phospholipase A2 inhibitors from marine organism. J Nat Prod. 55:1992;1701-1717.
28. Dennis E., Rhee S.G., Billah M.M., Hannun Y.A. Role of phospholipases in generating lipid second messengers in signal transduction. FASEB J. 5:1991;2068-2077.
29. Ek B., Hallberg C., Sjogren K.G., Hjalmarson A. Reoxygenation-induced cell damage of isolated neonatal ventricular myocytes can be reduced by chain-breaking antioxidants. Free Radic Biol Med. 16(1):1994;117-121.
30. Shappell S.B., Taylor A.A., Hughes H., Mitchell J.R., Anderson D.C., Smith C.W. Comparison of antioxidant and nonantioxidant lipoxygenase inhibitors on neutrophil function. Implications for pathogenesis of myocardial reperfusion injury. J Pharmacol Exp Ther. 252(2):1990;531-538.
31. Sgaragli G.P., Valoti M., Gorelli B., Fusi F., Palmi M., Mantovani P. Calcium antagonist and antiperoxidant proprties of some hindered phenols. Br J Pharmacol. 110(1):1993;369-377.
32. Kuzuya T., Hoshida S., Kim Y.et al. Free radical production coupled with arachidonate lipoxygenase reaction relates to reoxygenation induced myocardial cell injury. Cardiovasc Res. 27:1993;1056-1060.
33. Semb A.G., Ytrehus K., Vaage J., Myklebus R. Cardiac injury by activated leukocytes: effect of cyclooxygenase and lipoxygenase inhibition evaluated by electron microscopical morphometry. J Mol Cell Cardiol. 28(2):1996;311-320.
34. Hoshida S., Kuzuya T., Nishida M., Kim Y., Kitabatake A., Kamada T., Tada M. Attenuation of neutrophil function by inhibitors of arachidonate metabolism reduces the extent of canine myocardial infarction. Am J Cardiol. 63(10):1989;24E-28E.
35. Hashimoto H., Miyazawa K., Hagiwara M., Miyasaka K., Nakashima M. Beneficial effects of a new 5-lipoxygenase inhibitor on occlusion- and occlusion-reperfusion-induced myocardial injury. Arzneimittelforschung. 40(2 Pt 1):1990;126-129.
36. Ito T., Toki Y., Hieda N., Okumura K., Hashimoto H., Ogawa K., Satake T. Protective effects of a thromboxane synthetase inhibitor, a thromboxane antagonist, a lipoxygenase inhibitor and a leukotriene C4, D4 antagonist on myocardial injury caused by acute myocardial infarction in the canine heart. Jpn Circ J. 53(9):1989;1115-1121.
37. Starkopf J., Bugge E., Ytrehus K. Preischemic bradykinin and ischaemic preconditioning in functional recovery of the globally ischaemic rat heart. Cardiovasc Res. 33:1997;63-70.
38. Bugge E., Ytrehus K. Endothelin-1 can reduce infarct size through protein kinase C and K-ATP channels in the isolated rat heart. Cardiovasc Res. 32:1996;920-929.
39. Munch-Ellingsen J., Bugge E., Ytrehus K. Blockade of the K-ATP channel by glibenclamide aggravates ischemic injury, and counteracts ischemic preconditioning. Basic Res Cardiol. 91:1996;382-388.
40. Parratt J.R., Kane K.A. K-ATP channels in ischaemic preconditioning. Cardiovasc Res. 28:1994;783-787.
41. Müller M., Szewczyk A., De Weille J.R., Lazdunski M. ATP-sensitive K+ channels in insulinoma cells are activated by nonesterified fatty acids. Biochem. 31:1992;4656-4661.
42. Xu X., Lee K.S. Dual effect of arachidonic acid on ATP-sensitive K+ current of coronary smooth muscle cells. Am J Physiol. 270:1996;H1957-H1962.
43. Buttner N., Siegelbaum S.A., Volterra A. Direct modulation of Aplysia S-K channels by a 12-lipoxygenase metabolite of arachidonic acid. Nature. 342:1989;553-555.